Ubiquitin carboxyl-terminal esterase L1 (UCHL1) S18Y polymorphism in patients with cataracts

Ophthalmic Genetics

Volumn 32, Issue 2, 2011, Pages 75-79

  Rudolph, Thiemo ^a,f   Sjölander, Annica ^a   Palmér, Mona Seibt ^a   Minthon, Lennart ^b,c   Wallin, Anders ^a   Andreasen, Niels ^d   Tasa, Gunnar ^e   Juronen, Erkki ^e   Blennow, Kaj ^a   Zetterberg, Henrik ^a   Zetterberg, Madeleine ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF TARTU   (Estonia)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cataract; ubiquitin; uchl1

Indexed keywords

UBIQUITIN; UBIQUITIN THIOLESTERASE;

ADULT; AGED; ARTICLE; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; UCLH1 GENE;

AGED; AGED, 80 AND OVER; CATARACT; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; UBIQUITIN THIOLESTERASE;

EID: 79955844186     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810.2010.544360     Document Type: Article

References (31)

1. Wilkinson KD, Lee KM, Deshpande S, et al. The neuron-specifc protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science. 1989;246(4930):670-673. (Pubitemid 19283361)
2. Liu Y, Fallon L, Lashuel HA, et al. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibil-ity. Cell. 2002;111(2):209-218. (Pubitemid 35292441)
3. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature. 1998;395(6701):451-452.
4. Carmine Belin A, Westerlund M, Bergman O, et al. S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associ-ated with decreased risk of Parkinson's disease in Sweden. Parkinsonism Relat. Disord. 2007;13(5):295-298. (Pubitemid 47002329)
5. Facheris M, Strain KJ, Lesnick TG, et al. UCHL1 is asso-ciated with Parkinson's disease: a case-unaffected sib-ling and case-unrelated control study. Neurosci. Lett. 2005;381(1-2):131-134. (Pubitemid 40693155)
6. Maraganore DM, Lesnick TG, Elbaz A, et al. UCHL1 is a Parkinson's disease susceptibility gene. Ann. Neurol. 2004;55(4):512-521. (Pubitemid 38391968)
7. Healy DG, Abou-Sleiman PM, Casas JP, et al. UCHL-1 is not a Parkinson's disease susceptibility gene. Ann. Neurol. 2006;59(4):627-633.
8. Xu E, Tang Y, Li D, Jia J. Polymorphism of HD and UCHL-1 genes in Huntington's disease. Journal of Clinical Neuroscience. 2009;16(11):1473-1477.
9. Xue S, Jia J. Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and spo-radic Alzheimer's disease in a Chinese Han population. Brain Res. 2006;1087(1):28-32. (Pubitemid 43783159)
10. Forero DA, Benítez B, Arboleda G, et al. Analysis of func¬tional polymorphisms in three synaptic plasticity-related genes (BDNF, COMT AND UCHL1) in Alzheimer's disease in Colombia. Neurosci. Res. 2006;55(3):334-341. (Pubitemid 43766406)
11. Zetterberg M, Sjolander A, von Otter M, et al. Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymor-phism in Alzheimer's disease. Molecular Neurodegeneration. 2010;5(1):11.
12. Diomedi-Camassei F, Ravà L, Lerut E, et al. Protein gene product 9.5 and ubiquitin are expressed in metabolically active epithelial cells of normal and pathologic human kid-ney. Nephrol. Dial. Transplant. 2005;20(12):2714-2719. (Pubitemid 41672270)
13. Bonfanti L, Candeo P, Piccinini M, et al. Distribution of protein gene product 9.5 (PGP 9.5) in the vertebrate retina: evidence that immunoreactivity is restricted to mam-malian horizontal and ganglion cells. J. Comp. Neurol. 1992;322(1):35-44.
14. Nakajima J, Mekada A, Nakamura J, et al. Expression of protein gene product 9.5 in the anterior lens epithe-lial cells of atopic cataracts. J Cataract Refract Surg. 2002;28(11):2035-2039. (Pubitemid 35379375)
15. Zetterberg M, Petersen A, Sjöstrand J, et al. Proteasome activ-ity in human lens nuclei and correlation with age, gender and severity of cataract. Curr. Eye Res. 2003;27(1):45-53. (Pubitemid 36936346)
16. Dudek EJ, Shang F, Valverde P, et al. Selectivity of the ubiquitin pathway for oxidatively modifed proteins: relevance to protein precipitation diseases. FASEB J. 2005;19(12):1707-1709. (Pubitemid 41429537)
17. Prince JA, Feuk L, Howell WM, et al. Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specifc hybridization (DASH): design criteria and assay validation. Genome Res. 2001;11(1):152-162. (Pubitemid 32117961)
18. Takemoto L, Sorensen CM. Protein-protein interactions and lens transparency. Exp. Eye Res. 2008;87(6):496-501.
19. Delaye M, Tardieu A. Short-range order of crystal-lin proteins accounts for eye lens transparency. Nature. 1983;302(5907):415-417. (Pubitemid 13164324)
20. Oddo S. The ubiquitin-proteasome system in Alzheimer's disease. J. Cell. Mol. Med. 2008;12(2):363-373. (Pubitemid 351555121)
21. Elbaz A, Levecque C, Clavel J, et al. S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: Evidence for an age-dependent relationship. Movement Disorders. 2003;18(2):130-137. (Pubitemid 36305455)
22. Maraganore DM, Farrer MJ, Hardy JA, et al. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology. 1999;53(8):1858-1860. (Pubitemid 29530367)
23. Hutter CM, Samii A, Factor SA, et al. Lack of evidence for an association between UCHL1 S18Y and Parkinson's dis-ease. Eur. J. Neurol. 2008;15(2):134-139.
24. Klein BE, Klein R, Lee KE. Incidence of age-related cata-ract: the Beaver Dam Eye Study. Arch. Ophthalmol. 1998;116(2):219-225.
25. Jung T, Catalgol B, Grune T. The proteasomal system. Mol. Aspects Med. 2009;30(4):191-296.
26. Zetterberg H, Bath M, Zetterberg M, et al. The Szilard Hypothesis on the nature of aging revisited. Genetics. 2009;182(1):3-9.
27. Yu J, Ding S, Chang C, et al. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. Carcinogenesis. 2009;30(9):1562-1570.
28. Makishima H, Cazzolli H, Szpurka H, et al. Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies. J. Clin. Oncol. 2009;27(36):6109-6116.
29. Ragland M, Hutter C, Zabetian C, et al. Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson's Disease: a HuGE review and meta-analysis. AM J. Epidemiol. 2009;170(11):1344- 1357.
30. Healy DG, Abou-Sleiman PM, Wood NW. Genetic causes of Parkinson's disease: UCHL-1. Cell Tissue Res. 2004;318(1):189-194. (Pubitemid 39362639)
31. Walsh DM, Selkoe DJ. A beta Oligomers\a decade of dis-covery. J Neurochem. 2007;101(5):1172-1184.